A high level of proteins in the NOTCH signaling pathway and GFAP was commonly seen in both neuronal-glial stem/precursor and glioma stem-like cells [9], which is consistent with the neural stem cell phenotype of cells expected for NS-cultures of GBM. This evidence concerns the gene GFAP and central nervous system cancer.